Literature DB >> 2461892

The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks.

M C Kew1, A McKnight, J Hodkinson, S Bukofzer, J D Esser.   

Abstract

Membranous obstruction of the inferior vena cava has been incriminated as a risk factor for hepatocellular carcinoma in South African Blacks and in Japanese. However, the frequency with which this anomaly is found in patients with hepatocellular carcinoma, and hence its numerical importance as an etiological association of the tumor, has not been ascertained. Using radionuclide and contrast venography as well as necropsy and laparotomy examination, we investigated 162 unselected southern African Blacks with hepatocellular carcinoma together with appropriate controls for the presence of membranous obstruction of the inferior vena cava. Membranous obstruction of the inferior vena cava was detected in six of 162 (3.7%) hepatocellular carcinoma patients, compared with one of 279 subjects (0.36% p = 0.011) dying a violent death, none of 55 patients (p = 0.169) with malignant disease other than hepatocellular carcinoma and eight of 150 patients (5.3%; p = 0.336) being investigated for conditions which might have been associated with membranous obstruction of the inferior vena cava. Six of the 15 individuals (40%) found to have membranous obstruction of the inferior vena cava had concomitant hepatocellular carcinoma, confirming that membranous obstruction of the inferior vena cava constitutes a risk factor for the development of the tumor. However, only a very small proportion of hepatocellular carcinoma patients have this abnormality, so that it is a minor causal association of the tumor only.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2461892     DOI: 10.1002/hep.1840090121

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava).

Authors:  Santosh Man Shrestha
Journal:  World J Hepatol       Date:  2015-04-28

Review 2.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

3.  Rapid development of a hepatocellular carcinoma in isolated thrombosis of hepatic veins (classic Budd-Chiari syndrome): case report and review of literature.

Authors:  Jens Walldorf; Andrea Tannapfel; Hans Jürgen Holzhausen; Christian Wittekind; Thomas Seufferlein; Utz Settmacher; Wolfgang E Fleig; Matthias M Dollinger
Journal:  BMJ Case Rep       Date:  2009-11-29

4.  Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Int       Date:  2009-01-23       Impact factor: 6.047

5.  Splenomegaly and hypersplenism in hepatic vena cava syndrome.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Forum       Date:  2021-05-24

6.  Ultrasound study in the diagnosis of primary Budd-Chiari syndrome (obstruction of the inferior vena cava).

Authors:  H Sakugawa; A Higashionna; T Oyakawa; K Kadena; F Kinjo; A Saito
Journal:  Gastroenterol Jpn       Date:  1992-02

7.  Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea.

Authors:  Hana Park; Jin Young Yoon; Kyeong Hye Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

8.  A Nationwide Analysis of Budd-Chiari Syndrome in the United States.

Authors:  Joseph J Alukal; Talan Zhang; Paul J Thuluvath
Journal:  J Clin Exp Hepatol       Date:  2020-08-15

9.  Rapidly progressing Budd-Chiari syndrome complicated by hepatocellular carcinoma.

Authors:  Jeong Won Jang; Seung Kew Yoon; Si Hyun Bae; Jong Young Choi; Kyu Won Chung; Hee Sik Sun
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884

10.  Combining angioplasty with percutaneous microwave ablation for treating primary Budd-Chiari syndrome associated with hepatocellular carcinoma in two patients: A case report.

Authors:  Qing-Qiao Zhang; Mao-Heng Zu; Hao Xu; Yu-Ming Gu; Wen-Liang Wang; Zhi-Kang Gao
Journal:  Oncol Lett       Date:  2013-06-20       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.